For those interested, here is a relayed WHO report from the CDC on the increased circulation of Mycoplasma pneumoniae since May and a more recent uptick in RSV, flu and adenovirus

From here:

Pneumonia outbreak in Chinese kids linked to known pathogens | CIDRAP (umn.edu)

"Some of these increases are earlier in the season than historically experienced, but not unexpected given the lifting of COVID-19 restrictions, as similarly experienced in other countries," the WHO said.

“Officials with the Chinese Center for Disease Control and Prevention and the Beijing Children's Hospital told the WHO that there has been no detection of any unusual or novel pathogen, nor any change in disease presentation. They also said the increase in respiratory illness in children has not exceeded local hospital capacities.”

So, there you have it. Let’s hope it’s not “famous last words” for what appears to be a bacterial infection.

Of course, there is absolutely zero evidence that the 3 billion doses of whatever was in the Chinese C19 vaccinations (that were not Modified mRNA based) had anything to do with any lowering of any immune capabilities.

Here’s a clinical trial for the Sinovac Biotech vaccine which has, no doubt, been adjusted to suit the changing forms of spike protein carriers.

Outside Chine, trials were also conducted in Brazil, Chile, Turkey and the Philippines.

Sinovac Announces Phase III Results of Its COVID-19 Vaccine | Business Wire

“As of December 16, 2020, there were 12,396 health workers over 18 years old enrolled. A total of 253 positive cases were collected during the observation period. After 14 days following vaccination with 2 doses of vaccine following a 0, 14 day schedule, the efficacy rate against diseases caused by COVID-19 was 50.65% for all cases, 83.70% for cases requiring medical treatment, and 100.00% for hospitalized, severe, and fatal cases.”

Pretty impressive for those who suffered severe, serious and fatal, even medical treatment! I wonder what happened later on.

I will stick a few charts up for Brazil, Turkey and Chile (no data for Indonesia:

Manufacturers of doses in Chile here – no data for Turkey or Brazil.

COVID-19 vaccine doses administered by manufacturer, Chile (ourworldindata.org)

Lots of Sinovac in Chile - plus excess mortality ranging between 15 and 20% post injections.

Out of interest, from here: 15 December 2022:

Ivermectin Treatment for Covid-19 | NEJM

“The prespecified threshold for the clinical utility of ivermectin was a 37.5% difference, as compared with placebo, in the relative risk of a primary-outcome event, a threshold that is probably too conservative for a drug such as ivermectin. The relative risk estimates in the trial were compatible with reductions of up to 30% in the risk of hospitalization or prolonged observation and 51% in the risk of death with ivermectin.”

And this from 29 December 2020:

Ivermectin as a potential therapeutic in COVID-19. - Abstract - Europe PMC

“.. we are encouraged by a recent clinical investigation conducted by Dr. Sebastian Ugarte in Chile. In this trial, 65 patients diagnosed with SARS-CoV-2 infection were treated with an approved dose of ivermectin. 48 hours after such treatment, 85% of the patients did not have the virus as determined by PCR (https: //www.24horas, 2020). Moreover, this drug appears to be well tolerated by all its hosts and having rare lethal human cases”

Onwards!

Please subscribe or donate via Ko-fi – any amount from 3 bucks upwards. Don’t worry and God Bless, if you can’t or don’t want to. Ko-fi donations here: https://ko-fi.com/peterhalligan - an annual subscription of 100 bucks is one third less than a $3 Ko-fi donation a week!